New England Journal Of Medicine Publishes Data From Phase 3 inTandem3 Study Of Sotagliflozin

Wednesday, September 13, 2017 1 min read

Key Takeaway: New England Journal Of Medicine Publishes Data From Phase 3 inTandem3 Study Of Sotagliflozin

Full Press Release Details

New England Journal Of Medicine Publishes Data From Phase 3 inTandem3 Study Of Sotagliflozin.